These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38100967)

  • 1. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
    Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
    J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
    Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
    Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrathin Clay Nanoparticles-Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy.
    Liu J; Zhan J; Zhang Y; Huang L; Yang J; Feng J; Ding L; Shen Z; Chen X
    Adv Mater; 2024 Mar; 36(9):e2309562. PubMed ID: 37939375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photothermal Fe
    Li Y; Chen J; Xia Q; Shang J; He Y; Li Z; Chen Y; Gao F; Yu X; Yuan Z; Yin P
    J Nanobiotechnology; 2024 Oct; 22(1):630. PubMed ID: 39415226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy.
    Yang N; Pan X; Zhou X; Liu Z; Yang J; Zhang J; Jia Z; Shen Q
    Adv Healthc Mater; 2024 Mar; 13(7):e2302752. PubMed ID: 37975280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
    Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
    Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
    Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
    Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen Vacancy-Rich Manganese Nanoflowers as Ferroptosis Inducers for Tumor Radiotherapy.
    Liu Y; Pi F; He L; Yang F; Chen T
    Small; 2024 Aug; 20(32):e2310118. PubMed ID: 38506599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
    Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis.
    Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
    Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
    Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
    Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
    Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.
    Hou M; Liu M; Yu H; Kou Y; Jia J; Zhou Q; Zhang F; Zhao D; Zhao T; Li X
    Nano Lett; 2024 Jan; 24(4):1284-1293. PubMed ID: 38230643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling.
    Kraft VAN; Bezjian CT; Pfeiffer S; Ringelstetter L; Müller C; Zandkarimi F; Merl-Pham J; Bao X; Anastasov N; Kössl J; Brandner S; Daniels JD; Schmitt-Kopplin P; Hauck SM; Stockwell BR; Hadian K; Schick JA
    ACS Cent Sci; 2020 Jan; 6(1):41-53. PubMed ID: 31989025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury.
    Feng Y; Feng Y; Gu L; Mo W; Wang X; Song B; Hong M; Geng F; Huang P; Yang H; Zhu W; Jiao Y; Zhang Q; Ding WQ; Cao J; Zhang S
    Exp Mol Med; 2024 May; 56(5):1107-1122. PubMed ID: 38689083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
    Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
    Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation.
    Cao W; Zhang X; Feng Y; Li R; Lu A; Li Z; Yu F; Sun L; Wang J; Wang Z; He H
    ACS Nano; 2024 Jul; 18(26):17267-17281. PubMed ID: 38871478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.